miR-425-5p targets TGF-β1/Smad2 signaling pathway to attenuate collagen fiber deposition in hypertrophic scar tissue in mice

doi:10.16352/j.issn.1001-6325.2023.03.393

Abstract

Abstract: Objective To investigate the role and mechanism of miR-425-5p in the formation of hypertrophic scar(HS).Methods The levels of miR-425-5p, transforming growth factor-β1 (TGF-β1) and SMAD family member 2 (Smad2) in 16 pairs of HS tissue and normal skin tissue were detected by RT-qPCR and Western blot. The fibroblast cells were divided into nine groups: control group, miR-425-5p-mimic group, NC-mimic group, miR-425-5p-inhibitor group, NC-inhibitor group, TGF-β1-pcDNA3.1 group, NC-pcDNA3.1 group, miR-425-5p-mimic+NC-pcDNA3.1 group and miR-425-5p-mimic+TGF-β1-pcDNA3.1 group. The cells were transfected with Lipofectamine 2000. The targeting relationship between miR-425-5p and TGF-β1 was verified by dual-luciferase reporter gene assay. Hypertrophic scars in mice were induced by bleomycin(BLM), and then the mice were randomly divided into 3 groups, control group (NC-agomir), model group (NC-agomir+BLM) and intervention model group transfected with miR-425-5p (miR-425-5p-agomir+BLM), mice were treated for 21 days. Collagen fiber deposition in HS tissue was detected by Masson's trichrome staining. The expressions of miR-425-5p, type Ⅰ collagen (Col-Ⅰ), type Ⅲ collagen (Col-Ⅲ), α-smooth muscle actin (α-SMA), TGF-β1 and Smad2 in tissues and cells were detected by RT-qPCR and Western blot. Results Compared with normal group, the expression of miR-425-5p in HS group was decreased (t=4.242, P＜0.001), while the mRNA and protein expression of TGF-β1 was increased(P＜0.001). Compared with control group, the mRNA and protein expression of Col-Ⅰ, Col-Ⅲ, α-SMA, TGF-β1 and Smad2 in miR-425-5p-mimic group were all decreased (P＜0.05). Compared with control group, mRNA and protein expression of Col-Ⅰ, Col-Ⅲ, α-SMA, TGF-β1 and Smad2 in miR-425-5p-inhibitor group was all increased(P＜0.05). After co-transfection with miR-425-5p-mimic, the relative luciferase activity of TGF-β1-3′-UTR-WT group was reduced as compared with TGF-β1-3′-UTR-MUT group (P＜0.05). Compared with miR-425-5p-mimic+NC-pcDNA3.1 group, mRNA and protein expression of Col-Ⅰ, Col-Ⅲ, α-SMA, TGF-β1 and Smad2 in miR-425-5p-mimic+TGF-β1-pcDNA3.1 group were all increased (P＜0.05). Compared with NC-agomir+BLM group, the relative collagen content of miR-425-5p-agomir+BLM group was decreased (P＜0.05) and the expression of miR-425-5p was increased (P＜0.05). The TGF-β1 mRNA and protein were decreased (P＜0.05).Conclusions The miR-425-5p is down-regulated in HS tissue, and up-regulated miR-425-5p inhibits collagen deposition and HS formation by inhibiting TGF-β1/Smad2 signaling pathway.

Key words: hypertrophic scar, miR-425-5p, collagen deposition, transforming growth factor-β1, Smad2

CLC Number:

R619.6

LIANG Yan, WANG Lijuan, WU Huilin. miR-425-5p targets TGF-β1/Smad2 signaling pathway to attenuate collagen fiber deposition in hypertrophic scar tissue in mice[J]. Basic & Clinical Medicine, 2023, 43(3): 393-401.

References 15

[1]	Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116: 281-297.
[2]	Nosalski R, Siedlinski M, Denby L, et al. T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension[J]. Circ Res, 2020, 126: 988-1003.
[3]	Zhao Z, Lin CY, Cheng K. SiRNA-and miRNA-based therapeutics for liver fibrosis[J]. Transl Res, 2019, 214: 17-29.
[4]	Chen L, Li J, Li Q, et al. Non-coding RNAs: the new insight on hypertrophic scar[J]. J Cell Biochem, 2017, 118: 1965-1968.
[5]	Xiao L, Tang T, Huang Y, et al. miR-564 promotes hypertrophic scar formation through TGF-β1 upregulation[J]. G Ital Dermatol Venereol, 2019, 154: 186-191.
[6]	Wang L, Liu J, Xie W, et al. miR-425 reduction causes aberrant proliferation and collagen synthesis through modulating TGF-β/Smad signaling in acute respiratory distress syndrome[J]. Int J Clin Exp Pathol, 2019, 12: 2604-2612.
[7]	Duan M, Zhang Y, Zhang H, et al. Epidermal stem cell-derived exosomes promote skin regeneration by downregulating transforming growth factor-β1 in wound healing[J]. Stem Cell Res Ther, 2020, 11: 452. doi: 10.1186/s13287-020-01971-6.
[8]	Fan C, El Andaloussi S, Lehto T, et al. Smad binding decoy reduces extracellular matrix expression in human hypertrophic scar fibroblasts[J]. Mol Med Rep, 2020, 22: 4589-4600.
[9]	Li YH, Yang J, Zheng Z, et al. Botulinum toxin type A attenuates hypertrophic scar formation via the inhibition of TGF-β1/Smad and ERK pathways[J]. J Cosmet Dermatol, 2021, 20: 1374-1380.
[10]	Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treat-ment[J]. Dermatol Surg, 2017, 43: 3-18.
[11]	苏江维, 余慧, 杜坤, 等. Notch1表达下调抑制病理性瘢痕成纤维细胞增殖并诱导其凋亡[J]. 基础医学与临床, 2020, 3: 328-333.
[12]	Wang L, Liu J, Xu B, et al. Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure[J]. Kaohsiung J Med Sci, 2018, 34: 626-633.
[13]	Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis[J]. Wound Repair Regen, 2016, 24: 215-222.
[14]	Shi W, Fang Y, Jiang Y, et al. Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-β1/Smad and Akt/mTOR pathways[J]. Bioengineered, 2021, 12: 4475-4488.
[15]	Zheng M, Li H, Sun L, et al. Interleukin-6 participates in human pancreatic stellate cell activation and collagen Ⅰ production via TGF-β1/Smad pathway[J]. Cytokine, 2021, 143: 155536. doi: 10.1016/j.cyto.2021.155536.